EGFR and colorectal carcinoma: ADAM-17, which has been implicated in the proteolytic cleavage of EGFR ligands, among other activities, has been shown to be upregulated in CRC tumor specimens compared with ADAM17 expression levels in normal colonic mucosa [14].